Alla Zamyatina

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 11

Top Venues

Pharmaceuticals (Basel, Switzerland)

Organic letters

ChemMedChem

Angewandte Chemie (International ed. in English)

University of Natural Resources and Life Sciences, Department of Chemistry

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Natural Resources and Life Sciences, Department of Chemistry

Austria

Dr., Assoc. Professor :: Department of Chemistry

University of Natural Resources and Life Sciences, Department of Chemistry

Austria

Dr., Univ. Assistant

Publications

Sebastian Strobl, Daniele Zucchetta, Tomáš Vašíček, Alessandro Monti, Alessandro Ruda, Göran Widmalm, Holger Heine, Alla Zamyatina
Nonreducing Sugar Scaffold Enables the Development of Immunomodulatory TLR4-specific LPS Mimetics with Picomolar Potency. Angewandte Chemie (International ed. in English) (2024)
Alessio Borio, Aurora Holgado, Christina Passegger, Herbert Strobl, Rudi Beyaert, Holger Heine, Alla Zamyatina
Exploring Species-Specificity in TLR4/MD-2 Inhibition with Amphiphilic Lipid A Mimicking Glycolipids. Molecules (Basel, Switzerland) 28 (16) (2023)
Holger Heine, Alla Zamyatina
Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Holger Heine, Alla Zamyatina
Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Sebastian Strobl, Karin Hofbauer, Holger Heine, Alla Zamyatina
Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (35) (2022)
Holger Heine, Alla Zamyatina
Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Holger Heine, Alla Zamyatina
Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Virgil Schijns, Dragomira Majhen, Peter van der Ley, Aneesh Thakur, Artur Summerfield, Rita Berisio, Cristina Nativi, Alberto Fernández-Tejada, Carmen Alvarez-Dominguez, Sveinbjorn Gizurarson, Alla Zamyatina, Antonio Molinaro, Camillo Rosano, Žiga Jakopin, İhsan GÜrsel, Siobhán McClean
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Pharmaceutics 13 (4) (2021)
Florian Adanitsch, Jianjin Shi, Feng Shao, Rudi Beyaert, Holger Heine, Alla Zamyatina
Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics. Chemical science 9 (16) (2018)
Alessio Borio, Aurora Holgado, Jose Antonio Garate, Rudi Beyaert, Holger Heine, Alla Zamyatina
Disaccharide-Based Anionic Amphiphiles as Potent Inhibitors of Lipopolysaccharide-Induced Inflammation. ChemMedChem 13 (21) (2018)
Ralph Hollaus, Paul Kosma, Alla Zamyatina
Stereoselective Synthesis of α- and β-l-Ara4N Glycosyl H-Phosphonates and a Neoglycoconjugate Comprising Glycosyl Phosphodiester Linked β-l-Ara4N. Organic letters 19 (1) (2016)

Alla Zamyatina.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alla Zamyatina